Home / Technology / This Biotech Stock Is Up 158% in a Year. What’s Driving It Higher?

This Biotech Stock Is Up 158% in a Year. What’s Driving It Higher?

Insight Molecular Diagnostics (IMDX) is a precision diagnostics company with disruptive transplant technology and strong recent price momentum. IMDX has surged 158% over the past year and is trading at a new two-year high. Shares maintain a 100% “Buy…

Insight Molecular Diagnostics (IMDX) is a precision diagnostics company with disruptive transplant technology and strong recent price momentum.
IMDX has surged 158% over the past year and is trading at a new two-year high.
Shares maintain a 100% “Buy… [4048 chars]

Source: Barchart | Published: 2025-11-12T16:15:02Z

Credit: Barchart

Tagged:

Leave a Reply

Your email address will not be published. Required fields are marked *